This illustration summarizes how integrated spatial transcriptomics, single-cell transcriptomics, single-cell epigenomics, and spatial epigenomics enable multi-dimensional profiling of the tumor ...

Join us for an insightful session where we explore how NGS proteomics is transforming our understanding of health and disease. Discover how proteomics integrates seamlessly with genomics, metabolomics ...

A study involving researchers from Karolinska Institutet indicates that prostate cancer can be diagnosed at an early stage through a simple urine sample. With the aid of AI and extensive analyses of ...

The Global Cancer Biomarkers Market is projected to grow at a CAGR of 8.6% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market was ...

Prostate cancer is one of the most common and deadly forms of cancer in men, yet early detection remains a major challenge. That difficulty lies in how subtle the disease can be in its earliest stages ...

The molecular understanding of brain tumors has undergone a profound transformation in recent years. Advances in genomics, ...

Spatial ribonucleic acid (RNA) transcriptomics measures gene expression while preserving each molecule’s coordinates in intact tissue, tying transcripts to histology and local microenvironments.

COVID-19 patient whole blood sequencing data was analyzed for chimeric RNA using STARfusion, SoapFuse, and EricScript. Predictions found by at least two software and those containing no ...

Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor development.

“New, more precise biomarkers than PSA can lead to earlier diagnosis and better prognoses for men with prostate cancer,” says Benson. “Moreover, it can reduce the number of unnecessary prostate ...